News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TrovaGene, Inc. Schedules Release Of Fourth Quarter And Year End 2013 Financial Results And Investor Conference Call


3/3/2014 7:02:56 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN DIEGO, March 3, 2014 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, announced today that it will report financial results for the quarter and year ended December 31, 2013 on Monday, March 17, 2014 at 4:00 p.m. Eastern Daylight Time (1:00 p.m. Pacific Daylight Time).

A molecular diagnostics company with unique intellectual property around the discovery that DNA and RNA, present in urine, can be diagnostic of cancer and infectious disease

Trovagene's management team will host a conference call on Monday, March 17, 2014 at 5:00 p.m. Eastern Daylight Time (2:00 p.m. Pacific Daylight Time) to discuss the results and update investors on the company's progress.

A live webcast of the call will be available online at www.trovagene.investorroom.com. To access the conference call, please dial (877) 870-4263 (domestic), (412) 317-0790 (international), or (855) 669-9657 (Canada), conference ID# 10042191. To access the telephone replay of the call, dial (877) 344-7529 (domestic) or (412) 317-0088 (international), replay ID# 10042191. The webcast and telephone replay will be archived on the company's website following the call.

About Trovagene, Inc.

Headquartered in San Diego, California, Trovagene is leveraging its patented technology for the detection of cell-free DNA and RNA, short nucleic acid fragments originating from normal and diseased cell death that can be isolated and detected from urine. Trovagene has a strong intellectual property asset as it relates to cell-free DNA and RNA testing in urine. It has U.S. and European patent applications and issued patents that cover testing for HPV and other infectious diseases, cancer, transplantation, prenatal and genetic testing.

Logo - http://photos.prnewswire.com/prnh/20120620/LA28014LOGO

Contact


Trovagene, Inc.

Amy Caterina

Investor Relations

+1 (858) 952-7593

acaterina@trovagene.com

www.trovagene.com

SOURCE Trovagene, Inc.



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES